chrisvoncsefalvay/vaers-outcomes huggingface dataset:
death Other pulmonary embolism without acute cor pulmonale Unspecified convulsions
Shots given 07/19 MMR the one I'm worried about Swollen Lymph Node on neck 07/24 Fever 101-102 07/26-07/28 Ear Infection 07/27 Broken out in rash all over (comes and goes 07/31 to present 08/06)
mom gave hx 105 fever; pt seen by MD; onset rash 28NOV; MD advised f/u PMD; called MD office 2DEC; fever due to URI
Information has been received from a physician concerning a 16 year old female patient with who was vaccinated with the first dose of GARDASIL and experienced amenorrhea for a few months. Patient is not pregnant. The patient's outcome was unknown at the date of the report. Patient sought unspecified medical attention. Additional information has been requested.
When I walked everything started to fade slowly, and while my mom was filling out papers I got really dizzy and my hands were shaking.  And when I sat down I started feeling hot and I started to sweat.
Information regarding Flumist was received from consumer regarding a 49 year old female pt who experienced sore throat with phlegm and fever < 100 deg. At 49 years of age, the pt received a dose on 12/2/03. The pt experienced sore throat with phlegm and fever < 100 deg on 12/3/03. The pt was treated with Tylenol but as of 12/3/03 the symptoms persisted. No additional info was available at the time of this report.
pt seen @ local Er 4AM w/t104 R;mom reported that pt had vomited x1;ER MD dx pt w/gastroenteritis @ the time;
Apr 13 th - 5 days later I was swimming, I had a high heart rate which stayed high 110. Went to doctor on 15 APr 2021 .6 days after vaccine.
This morning it was unsual to find that pain is different/ felt decrease pain; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (This morning it was unsual to find that pain is different/ felt decrease pain) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Chronic arthritis (He was due for knee replacement in 2 weeks of time.He stated normally, he used to have locked knees, very painful knee when he wakes up in the morning.).   On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (This morning it was unsual to find that pain is different/ felt decrease pain). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (This morning it was unsual to find that pain is different/ felt decrease pain) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
pain; inflammation; In her right leg, she now has constant pain; she felt something "different", a sensation throughout her body./she didn't feel comfortable walking in market; she is sick; foot kept slipping off of it; swelling; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 73 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. Relevant medical history included: "Rheumatoid Arthritis" (unspecified if ongoing); "Osteoarthritis" (unspecified if ongoing); "Pain" (unspecified if ongoing), notes: pain over the past 35 years. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary series immunization complete , MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: PAIN (non-serious), outcome "not recovered", described as "pain"; INFLAMMATION (non-serious), outcome "not recovered", described as "inflammation"; PAIN IN EXTREMITY (non-serious), outcome "not recovered", described as "In her right leg, she now has constant pain"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "she felt something "different", a sensation throughout her body./she didn't feel comfortable walking in market"; ILLNESS (non-serious), outcome "unknown", described as "she is sick"; LIMB DISCOMFORT (non-serious), outcome "unknown", described as "foot kept slipping off of it"; SWELLING (non-serious), outcome "not recovered", described as "swelling".  Additional information: Patient would like to know if her symptoms can be correlated with the booster dose, and mentions that she had no significant side effects from the primary series, and that she had never experienced pain like this before the booster. Patient mentions that condition (RA and OA) has changed steadily in terms of mobility and pain over the past 35 years. Patient is still having issues with the accelerator and now the brakes. Patient reports that she functioned reasonably well until that point, and noticed an immediate difference in her right foot. Prior to the booster, no issues with her left lower extremity, but now has inflammation on the left side and is having issues. The swelling does not subside with elevation like it used to, and has pain when she reclines. 1st attempt by phone to non-HCP to obtain mailing information. Phone answered by the patient who provided mailing address.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient received the vaccine on Friday and Saturday morning while attending a football game patient became very dizzy, everything went dark, and her blood pressure kept dropping upon rising. Patient was taken by ambulance to the hospital. She was given a bag of fluids for dehydration and discharged
This spontaneous report as received from a pharmacist refers to an approximately 84 years old male patient who on 25-APR-2014, was vaccinated with ZOSTAVAX lot # J010447 Exp: 22-APR-2014, 0.65 ml, subcutaneous in the left arm. Pharmacist reported 2 patients were vaccinated with expired ZOSTAVAX. Both patients vaccinated on 25-APR-2014. No adverse effects reported. No further details provided. The outcome of vaccinated with expired ZOSTAVAX vaccine was unknown. Same reporter link MARRS 1405USA002220. Additional information has been requested.
Patient presented for baseline colonoscopy and was found to be in A-fib on pre-op EKG.  Sent to cardiology for work-up that included cardiac ultrasound and catheterization.  No presenting symptoms.  However, patient has some anxiety..
Got the vaccine in the morning. In the evening, felt tired, body ache, nausea, swelling/painful arm at injection site. Had the same symptom with first vaccine.
Woke from nap with spasms/seizures lasting 5-10 seconds each, spaced apart about every 30 seconds to a minute. After a few hours, they gradually spaced to every few minutes apart. Overall duration lasted about 5 hours until spasms/seizures stopped while being transported from ER to another hospital via helicopter.
No reaction. 18 year old and older vaccine was given to a 17 year old.
pain/sore arm fatigue body aches sore/painful lymph node in armpit on side of injection
Hives on face and neck only in areas being treated for brown spots using SkinMedica Retinol Complex 1.0.  Hives lasted for 4 days despite using zertec allergy medicine.
Narrative:  COVID fully vaccinated, admitted on 5/24 found to be COVID positive on 5/30 incidentally
2/29 - Vaccine given.  3/1 - Swollen lips, bilateral thigh redness - put on Keflex, Benadryl.  3/3 - Lips better on Benadryl, left thigh still red - sent to ER.  Hospitalized for IV antibiotics.  6/2/08 Reviewed hospital medical records for 3/5-3/8/2008. FINAL DX: cellulitis s/p immunizations Records reveal patient experienced redness, warmth, pain, induration, bruising & swelling of left thigh injection site w/difficulty walking.  Had been transferred from outlying hospital for ped ortho evaluation for possible abscess.  Continued on IV antibiotics & was changed to vancomycin due to concern for MRSA after which patient improved markedly.  D/C to home on oral antibiotics.  4/15/08 Reviewed hospital medical records for 3/3-3/5//08. FINAL DX: cellulitis, pain, increased inflammatory markers Records reveal patient experienced fever, felt unwell, runny nose, decreased appetite, swollen lips.  There was redness, warmth, tenderness, induration, bruising & swelling left thigh injection site w/difficulty walking x 2 days.  Seen by PCP & dx w/cellulitis at injection site.  Tx w/antibiotics but worsened.  Seen again by PCP & sent to hospital for admit.  Tx w/IV antibiotics & had some improvement in cellulitis but still had exquisite pain of left leg.  Transferred to higher level of care for peds ortho evaluation.
Patient received expired dose of the Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna vaccine) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna vaccine). On 27-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided  No treatment medications were provided.   This case was linked to MOD-2021-338604, MOD-2021-338616 (Patient Link).
Patient was offered to be vaccinated against the Flu by the technician and she accepted. she also requested to have a covid booster. the FLU shot was processed through her insurance and a paid claim obtained. The pharmacist administered the Flu on the left arm and when trying to administer the covid on the right arm realized that she had  a bandage on. The pharmacist then asked why the bandage, it is then that she said she had a flu shot . on verifying from her profile, it was discovered that she had a flu on 09/03/23.  when the pharmacist tried to explain that she has been given two shots within a week, she seemed less bothered and left.
Nausea, inability to eat and dry heaving, muscle pain for 24 hours after the vaccination.  Starting immediately afterwards I have suffered from chronic abdominal bloating and excessive burping.  This has caused weight loss (from 175 pounds to 150 pounds), sleep loss due to burping at night, and severe distress and loss of quality of life.  The effects seem to be permanent.  Things I have tried to mitigate with little/no success:  Probiotics Activated Charcoal pills Spice teas FODMAP diet Low-sugar diet Dairy-free diet Fasting Endoscopy Breath test Antibiotics Peppermint oil pills Herbal bitters and other homeopathic remedies Adjusting food schedule Keeping a food diary Epsom Salt flush
Patient complains of dizziness for days after injection and diarrhea right after shot for 2 days.
sinus infection; This is a spontaneous report from a Pfizer Sponsored Program Covax support via a contactable consumer (patient, self-reported). A Female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on 01Mar2021, as a single dose for COVID-19 immunization. The patient's medical history included cancer and osteopetrosis (Prolia shots to prevent osteopetrosis). Concomitant medications were not reported. On an unspecified date, the patient experienced sinus infection. The patient was scheduled to start Prolia shots to pre-vent osteopetrosis and wanted to know if able to get injections prior to her second dose of the vaccine scheduled for 22Mar2021. She had to delay first injection of Prolia due to sinus infection after March 1st. Outcome of the event was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Patient had stomach pains for first 24 hours after 1st Covid dose.  He treated with acetaminophen and pains subsided.
Patient was provided 3rd dose of Pfizer on 1/15/2021  lot number FJ6369 exp date 3/29/2022  writer was not present when symptoms started such as fever patient on was routine Tylenol staff at assisted living facility reported fever record daily stating on 1/16/21
Headache; Nausea; Body aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), MYALGIA (Body aches), CHILLS (Chills) and NAUSEA (Nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical history information was provided by the reporter.  Concomitant products included CALCIUM for Bone density increased, GABAPENTIN (NEURONTIN) for Headache, LEVOTHYROXINE, FISH OIL, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and VITAMIN B COMPLEX for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced MYALGIA (Body aches) and CHILLS (Chills). On 30-Jan-2021 at 2:30 AM, the patient experienced HEADACHE (Headache) and NAUSEA (Nausea). On 31-Jan-2021, HEADACHE (Headache), MYALGIA (Body aches) and CHILLS (Chills) had resolved. On 11-Apr-2021, NAUSEA (Nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: follow up received on 29-apr-2021:containes no new information On 06-May-2021: The follow up case received on 06-MAY-2021. Concomitant indications, dosage and start date were added. Lab test is added.
pt had nothing to eat or drink today. pt. reported he was light headed. BP:122/75 HR:81 O2:98
it was admin to a patient via IM injection instead of subcutaneously; This spontaneous report was received from a medical assistant referring to a patient of unreported age and gender.   No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 28-FEB-2022 the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) via intramuscular injection instead of subcutaneously (incorrect route of product administration) for prophylaxis (lot number: u028181, expiration date: 08-MAR-2023; concentration, dose, vaccination scheme frequency, and anatomical location were not reported).
4/3-was feeling unwell and didn't eat much 4/4-could not get out of bed without assistance in the am; vomited mucus and could not eat; refused Easter dinner. 4/5-woke up and had trouble breathing; ambulance called "she had no pulse, and had trouble breathing" Throughout had no fever or chills.
Shingles; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Jun2021 at 19:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included guillain barre syndrome. The patient had known allergies to sulfa and penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine, liothyronine (NP THYROID), metformin hydrochloride, empagliflozin (SYNJARDY), dulaglutide (TRULICITY) and levocetirizine dihydrochloride (XYZAL); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Jul2021, the patient experienced shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with antiviral medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles was recovering at the time of this report.  The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
upper respiratory infection; This spontaneous case was reported by a consumer and describes the occurrence of UPPER RESPIRATORY TRACT INFECTION (upper respiratory infection) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced UPPER RESPIRATORY TRACT INFECTION (upper respiratory infection). At the time of the report, UPPER RESPIRATORY TRACT INFECTION (upper respiratory infection) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Patient inquiring about whether to receive the second shot while experiencing an upper respiratory infection. No concomitant medications were reported. No treatment was reported.
This case was reported by a healthcare professional and described the occurrence of nausea in a 12-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). There were no concurrent medications and no relevant medical history. On 15 September 2010 at 16:30 the subject inadvertently received a dose of FLULAVAL at 0.5 ml in the left arm. On 16 September 2010, 1 day after vaccination with FLULAVAL, the subject experienced nausea, diarrhea and sore throat. It was indicated that the events lasted for 24 hours (outcome of 16 September 2010), however, they were noted as improved at the time of report. All events were considered unrelated to treatment with FLULAVAL.
Information has been received from both a 68 year old male patient and his wife concerning the patient who on 29-JUN-2009 and 24-SEP-2009 separately was vaccinated with a dose of ZOSTAVAX (Merck) and a dose of influenza virus vaccine (unspecified, not H1N1). Concomitant therapy included SYNTHROID. Subsequently the patient was experiencing a burning, prickly feeling all over his body. This happened at the nerve endings, from his toes to his head; he stated he felt like his skin was on fire. The patient had been tested for Guillain-Barre syndrome (negative), Valley Fever (negative) and a brain MRI (normal). He stated he had large needles stuck into him, and he was treated for post herpetic neuralgia even though he "never had shingles or been diagnosed with shingles." The patient was treated with prednisone and LYRICA. The wife said her husband had a severe reaction; he did not know what day it was or time of day when taking those two medications. Wife said her husband had been referred to an internist, neurologist, hematologist, and nothing was found. The patient was not recovered at the time of reporting. The patient would have a followup visit with his physician the first of July, 2010. Additional information is not expected.
lost hearing; On the same evening I woke up vomiting and felt the whole living; On the same evening I woke up vomiting and felt the whole living; I couldn't move; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 05May2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: HYPOKINESIA (hospitalization) with onset 08May2021, outcome "unknown", described as "I couldn't move"; VOMITING (hospitalization), VERTIGO (hospitalization) all with onset 08May2021, outcome "unknown" and all described as "On the same evening I woke up vomiting and felt the whole living"; DEAFNESS (hospitalization) with onset 08May2021, outcome "unknown", described as "lost hearing". The events "lost hearing", "on the same evening i woke up vomiting and felt the whole living" and "i couldn't move" required emergency room visit. Therapeutic measures were taken as a result of deafness, vomiting, vertigo, hypokinesia.  Clinical course: Patient reported, "I was wondering if Pfizer offers any compensation regarding the Covid vaccine side effects. On the 3rd day, after taking the 2nd shot on 05May2021, I lost hearing on my right ear so I had to go to the emergency. On the same evening I woke up vomiting and felt the whole living room was spinning. I couldn't move so I called and was sent to a hospital for 8 days and to rehab. I asked the rehab to release me so I could see ENT. Four steroid shots didn't help."  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Nurse).  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 43 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient took Other medication in 2weeks and details provided as patient administered Paxlovid orally from 16May2022 to 20May2022 for COVID 19 treatment. Adverse event reported as on 24May2022-COVID symptoms returned mild nasal drainage, sinus headache, sore throat and Fatigue. Patient was Recovering.Treatment for AE: No. Had no known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the events Drug ineffective and covid 19 and the role of suspect drug cannot be ruled out. The case will be reassessed once new information is available.
Employee received Moderna COVID vaccine at approximately 08:30 on 12/28/2020. At approximately 16:00 that same day, she began experiencing HA, nausea, and chills. She developed a fever of 102.7 at 21:00 that evening. Employee notified her manager and EHS of event